The Pulse of New York Tech
Gero is a next generation AI drug discovery company designing therapies against complex diseases. Founded by Maxim Kholin and Peter Fedichev in 2012, Gero is backed by investors that include Bulba Ventures and is headquartered in Singapore.
WRITE FOR US
NYC TECH EVENTS
NYC TECH NEWS
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.